Hello AWSIM!
The article GLP-1s for Weight Loss – A Triumph of Marketing over Patient Care by Angela Meadows, Louise Adams and me was just published!
The paper separates marketing hype from what the research actually finds to help you parse and respond to claims about GLP-1s for weight loss and cardiovascular health. We also created supplemental tables that offer clear views of the phase 3 weight loss trials of semaglutide and tirzepatide, so that you can clearly see information like adverse events data and how many people in the trials failed to reach the weight loss endpoints, which we hope will be helpful for both refuting overblown claims and possible informed consent conversations.
The article is open access an you can find it here:
https://www.tandfonline.com/doi/full/10.1080/21604851.2026.2646492